Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: cavan who wrote (3253)	9/30/2002 2:16:29 PM
From: scaram(o)uche	Respond to of 4974

Jerry: Traditionally, this thread is not used for stock-specific discussion. However, to avoid the embarrassment that I'd expose myself to if I sent you elsewhere, so....... Yes, I believe it's a buy at under $2. If you asked me, a few weeks ago, if it would ever see sub-$2 again, I'd have said that the chances approached zero. So, first "grain of salt" disclaimer. I like antegren, but an anti-integren project from MLNM, that I thought had a good shot, just failed for Crohn's. Second "grain of salt" disclaimer. I'm a small cap biotech investor, which means that I have learned to tolerate enormous losses among given components of a basket. Third "grain of salt" disclaimer. There is a contributor, "Icebrg", who posts to the ELN thread. IMO, his comments are insightful and balanced. IMO, he knows the company better than others around SI. Good luck! Rick